ANDRAŠINA, Tomáš, Jaroslav JURÁČEK, Jan ZAVADIL, Barbora ČECHOVÁ, Tomáš ROHAN, Petra VESELÁ, Mor PALDOR, Ondřej SLABÝ and Nahum GOLDBERG. Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs. Journal of vascular and interventional radiology. New York: Lippincott Williams & Wilkins, 2021, vol. 32, No 3, p. 403-411. ISSN 1051-0443. Available from: https://dx.doi.org/10.1016/j.jvir.2020.10.024.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs
Authors ANDRAŠINA, Tomáš (703 Slovakia, guarantor, belonging to the institution), Jaroslav JURÁČEK (203 Czech Republic, belonging to the institution), Jan ZAVADIL (203 Czech Republic, belonging to the institution), Barbora ČECHOVÁ (203 Czech Republic, belonging to the institution), Tomáš ROHAN (203 Czech Republic, belonging to the institution), Petra VESELÁ (203 Czech Republic, belonging to the institution), Mor PALDOR, Ondřej SLABÝ (203 Czech Republic, belonging to the institution) and Nahum GOLDBERG.
Edition Journal of vascular and interventional radiology, New York, Lippincott Williams & Wilkins, 2021, 1051-0443.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.682
RIV identification code RIV/00216224:14110/21:00121875
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.jvir.2020.10.024
UT WoS 000645600200011
Keywords in English EPITHELIAL-MESENCHYMAL TRANSITION; RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; SERUM MICRORNA-210; CANCER; EXPRESSION; MECHANISM; GROWTH; PROGRESSION; METASTASIS
Tags 14110216
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/8/2021 08:31.
Abstract
Purpose: To determine whether the levels of circulating microRNAs (miRNAs) are altered in patients undergoing thermal ablation and chemoembolization and whether these changes are predictive of a clinical outcome. Material and Methods: This prospective study consisted of 43 patients diagnosed with hepatocellular carcinoma (n = 15) and intrahepatic colorectal cancer metastases (n = 28) treated with thermal ablation (n = 23; radiofrequency [n = 6] or microwave [n = 19]), chemoembolization using drug-eluting embolics (n = 18), or both (n = 2). Four blood samples (immediately before the intervention and 60-90 minutes, 24 hours, and 7 days after the intervention) were taken to measure the plasma concentrations of miRNAs related to hypoxia (miR-21 and miR-210), liver injury (miR-122), epithelial-mesenchymal transition (miR-200a), and apoptosis (miR-34a) using miRNA-specific TaqMan assays and quantitative real-time polymerase chain reaction. Tumor burden and treatment response at 3 months were evaluated using the modified response evaluation criteria in solid tumors. The miRNA results were compared with clinical outcomes (Mann-Whitney U test, Wilcoxon matched-pair test). Results: Dynamic changes in the circulating miRNA levels were observed following both the interventions. For thermal ablation, significant increases in miR-21, miR-210, miR-122, miR-200a, and miR-34a concentrations peaked 60-90 minutes after the intervention (P < .01). However, for transarterial chemoembolization, maximum increases in the miRNA concentrations were observed at 24 hours after the intervention for miR-21, miR-210, miR-122, miR-200a, and miR-34a (P < .05). The increased concentrations of the circulating miRNAs were followed by a subsequent decline to baseline by 7 days. For the thermal ablation (but not chemoembolization) patients, elevations in the miR-210 and miR-200a levels were associated with early progressive disease at 3 months (P = .040 and P = .012, respectively). Conclusions: Increased but dynamic levels of circulating miRNAs are present following interventional oncologic procedures and may prove useful as biomarkers for the monitoring of clinical outcomes.
Links
MUNI/A/1488/2019, interní kód MUName: Význam radiologických intervencí a pokročilých zobrazovacích metod v diagnostice a léčbě onkologických pacientů
Investor: Masaryk University, Category A
PrintDisplayed: 26/4/2024 19:51